Nomogram predicted recurrence-free survival after resection of GIST

DiMarcantonio, Tina; Haigh, Christen; Harris, Jason; Lawrence, Leah
November 2009
Hem/Onc Today;11/10/2009, Vol. 10 Issue 21, p23
The article discusses a study by J.S. Gold and colleagues about the effectiveness of nomogram or computerized tool which accounted for prognostic criteria in identifying cancer recurrence published in the journal "Lancet Oncology."


Related Articles

  • PCa nomograms accurate regardless of patient race. Susman, Ed // Urology Times;Aug2002, Vol. 30 Issue 8, p26 

    Focuses on the correlation between prostate cancer nomograms and outcome. Utilization of Kattan nomograms in predicting disease progression; Survival of African-American males with prostate cancer; Assessment of disease recurrence.

  • Three models to predict axillary lymph node involvement in breast cancer validated.  // Hem/Onc Today;11/25/2009, Vol. 10 Issue 22, p36 

    The article describes the models applied for the prediction of the involvement of four or more axillary lymph nodes in patients with breast cancer, the Louisville score excluding method of detection, the Louisville score including method of detection, and the Katz nomogram.

  • Nomogram forecasts outcome of 3-D radiotherapy. Tennant, Scott // Urology Times;Dec2000, Vol. 28 Issue 12, p18 

    Focuses on the use of nomograms for predicting treatment outcome following three-dimensional conformal radiotherapy for localized prostate cancer in Sao Paulo, Brazil. Comparison between nomogram and brachytherapy prediction tool in terms of patient discrimination; Construction and validation...

  • Nomogram may be useful predictor of PCa recurrence. Scheck, Anne // Urology Times;May99, Vol. 27 Issue 5, p4 

    Highlights the results of the reliability tests being conducted by urologists at Memorial Sloan-Kettering Cancer Center in New York City on a nomogram for predicting the recurrence probability of prostate cancer (PCa). Scheme of the nomogram's function; Predictive factors for the disease;...

  • Nomogram predicts survival in hormone-refractory PCa. Guttman, Cheryl // Urology Times;Sep2007, Vol. 35 Issue 11, p18 

    The article reports on the development of a nomogram to predict survival the probability of men with metastatic hormone-refractory prostate cancer in Chicago, Illinois. This nomogram is developed from independent predictors. According to Dr. Andrew J. Armstrong, it represents an easy-to-use tool...

  • Prediction of involvement of sentinel and nonsentinel lymph nodes in a Canadian population with breast cancer. Ramjeesingh, Ravi; Quan, May Lynn; Gardner, Sandra; Holloway, Claire M. B. // Canadian Journal of Surgery;Feb2009, Vol. 52 Issue 1, p23 

    Background: We sought to identify criteria for the intraoperative assessment of sentinel lymph node (SLN) involvement in women with early breast cancer. We also sought to determine whether the SLN nomogram developed by the Memorial Sloan- Kettering Cancer Center (MSKCC) to predict nonsentinel...

  • Prediction of metachronous multiple primary cancers following the curative resection of gastric cancer. Chan Kim; Hong Jae Chon; Beodeul Kang; Kiyeol Kim; Hei-Cheul Jeung; Hyun Cheol Chung; Sung Hoon Noh; Sun Young Rha // BMC Cancer;2013, Vol. 13 Issue 1, p1 

    Background: Due to improved survival rate, gastric cancer (GC) patients have an increased risk of developing multiple primary cancer (MPC). The purpose of this study is to evaluate the clinicopathological features of MPC and to generate useful tools for the prediction of metachronous MPC...

  • Use of Gene Signatures to Improve Risk Estimation in Cancer. Chiang-Ching Huang; Bredel, Markus // JAMA: Journal of the American Medical Association;4/2/2008, Vol. 299 Issue 13, p1605 

    This article presents the authors' views on the use of gene signatures to improve prognosis and risk estimation in cancer. The authors reflect on how doctors make therapeutic decisions about breast cancer patients through clinicopathological parameters, which can inaccurately assess risks. The...

  • THE PREDICTIVE PROBABILITY OF TWO DIFFERENT BREAST CANCER NOMOGRAMS FOR NON SENTINEL AXILLARY LYMPH NODE METASTASIS IN POSITIVE SENTINEL LYMPH NODE BIOPSY. Gür, Akif Serhat; Ünal, Bülent; Johnson, Ronald; Ahrendt, Gretchen; Bonaventura, Marguerite; Evrensel, Türkkan; Soran, Atilla // Meme Sagligi Dergisi / Journal of Breast Health;2008, Vol. 4 Issue 3, p169 

    INTRODUCTION: Non sentinel axillary lymph node metastasis (NSLNM) occurs in 35-50% of breast cancer (BC) patients having positive sentinel lymph nodes (SLN). A nomogram which includes 8 variables was developed at Memorial Sloan Kettering Cancer Center (MSKCC) in 2003 and it has been validated at...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics